Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Estrogen Receptor beta as a Therapeutic Target in Breast Cancer Stem Cells
Karolinska Institute, Sweden.
Karolinska Institute, Sweden.
Karolinska Institute, Sweden.
Karolinska Institute, Sweden; Karolinska University of Lab, Sweden.
Show others and affiliations
2017 (English)In: Journal of the National Cancer Institute, ISSN 0027-8874, E-ISSN 1460-2105, Vol. 109, no 3, djw236Article in journal (Refereed) Published
Abstract [en]

Background: Breast cancer cells with tumor-initiating capabilities (BSCs) are considered to maintain tumor growth and govern metastasis. Hence, targeting BSCs will be crucial to achieve successful treatment of breast cancer. Methods: We characterized mammospheres derived from more than 40 cancer patients and two breast cancer cell lines for the expression of estrogen receptors (ERs) and stem cell markers. Mammosphere formation and proliferation assays were performed on cells from 19 cancer patients and five healthy individuals after incubation with ER-subtype selective ligands. Transcriptional analysis was performed to identify pathways activated in ER beta-stimulated mammospheres and verified using in vitro experiments. Xenograft models (n = 4 or 5 per group) were used to study the role of ERs during tumorigenesis. Results: We identified an absence of ERa but upregulation of ER beta in BSCs associated with phenotypic stem cell markers and responsible for the proliferative role of estrogens. Knockdown of ER beta caused a reduction of mammosphere formation in cell lines and in patient-derived cancer cells (40.7%, 26.8%, and 39.1%, respectively). Gene set enrichment analysis identified glycolysis-related pathways (false discovery rate amp;lt; 0.001) upregulated in ER beta-activated mammospheres. We observed that tamoxifen or fulvestrant alone was insufficient to block proliferation of patient-derived BSCs while this could be accomplished by a selective inhibitor of ER beta (PHTPP; 53.7% in luminal and 45.5% in triple-negative breast cancers). Furthermore, PHTPP reduced tumor initiation in two patient-derived xenografts (75.9% and 59.1% reduction in tumor volume, respectively) and potentiated tamoxifen-mediated inhibition of tumor growth in MCF7 xenografts. Conclusion: We identify ER beta as a mediator of estrogen action in BSCs and a novel target for endocrine therapy.

Place, publisher, year, edition, pages
OXFORD UNIV PRESS INC , 2017. Vol. 109, no 3, djw236
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:liu:diva-136043DOI: 10.1093/jnci/djw236ISI: 000396773900013OAI: oai:DiVA.org:liu-136043DiVA: diva2:1084882
Note

Funding Agencies|Swedish Society of Medicine; Swedish Society for Medical Research (SSMF); Magnus Bergvalls Stiftelse; Karolinska Institutes Theme Center in Breast Cancer (BRECT); Linnecenter for Prevention of Breast and Prostate cancer (CRisP); Swedish Cancer Society; Stockholm Cancer Society; King Gustav V Jubilee Fund; Karolinska Institutet; Stockholm County Council Research Strategy Committee; Swedish Breast Cancer Association; Science for Life-Astra Zeneca; Marie Curie Actions via the VINNOVA program Mobility for Growth [291795]

Available from: 2017-03-27 Created: 2017-03-27 Last updated: 2017-04-14

Open Access in DiVA

fulltext(2425 kB)18 downloads
File information
File name FULLTEXT01.pdfFile size 2425 kBChecksum SHA-512
727ae1b2fde4bce300d3c27b4765f79b3a4fa32f1e1db684275acac7f11c6655c39974b41e39cc7e38ec70361db48f377edbcb7ee97ebc5a7eeae75203c281c3
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Linder, Stig
By organisation
Division of Drug ResearchFaculty of Medicine and Health Sciences
In the same journal
Journal of the National Cancer Institute
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 18 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 130 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf